PPE and Air Hygiene for Flu Prevention

(EMIT-2 Trial)

No longer recruiting at 1 trial location
JW
WC
SL
Overseen BySarah Litts, MS, BSN, RN
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Maryland, Baltimore
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand how personal protective equipment (PPE) can prevent the airborne spread of the flu. Participants are divided into groups: one uses PPE to determine its effectiveness in stopping flu transmission, while the other does not. The trial seeks individuals who have recently had the flu or have not had it but are willing to use PPE for the study. Ideal candidates do not smoke or have complex health issues requiring ongoing medical treatment. As an unphased trial, this study allows participants to contribute to important research on flu prevention.

Will I have to stop taking my current medications?

The trial does not specify if you must stop taking your current medications. However, if you are on medications that suppress the immune system or treat significant medical conditions like respiratory or cardiovascular diseases, you may not be eligible to participate.

What prior data suggests that personal protective equipment (PPE) is safe for flu prevention?

Research has shown that personal protective equipment (PPE), such as masks, gloves, and face shields, is generally safe to use. Designed to protect against germs, these items are commonly used in healthcare settings. Studies have found that PPE, when used correctly, can reduce the risk of infection without harming the user.

No major reports of problems from wearing PPE have emerged. However, proper use is crucial for effectiveness. For instance, face masks should fit snugly, and hands should be clean when putting on gloves. This ensures that PPE remains a safe and effective method for preventing flu and other infections.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how personal protective equipment (PPE) might prevent the spread of influenza. Unlike typical flu prevention methods, such as vaccines and antiviral medications, this approach focuses on using PPE to block airborne transmission. This trial could reveal how effective PPE is as a preventive measure, potentially offering a simple and accessible way to reduce flu transmission, especially in settings where vaccines aren't available or effective.

What evidence suggests that personal protective equipment is effective for flu prevention?

This trial will compare the use of personal protective equipment (PPE) with no intervention for flu prevention. Studies have shown that face masks can greatly protect healthcare workers from infections. However, research on their effectiveness for the general public remains less clear. Some reviews have found no strong evidence that face masks reduce flu infections among everyday people. Gloves, although used in some situations, have not shown a clear effect on stopping respiratory viruses like the flu. Overall, PPE might help but does not guarantee flu prevention. It is best used as part of a broader prevention strategy.26789

Are You a Good Fit for This Trial?

This trial is for healthy adults aged 18-49 who have recently contracted the flu. Participants must understand the study, stay in a research unit for about 5 days, and attend follow-ups. Pregnant or breastfeeding women, smokers, those with severe allergies to medicines, immunosuppressed individuals or those on certain medications cannot join.

Inclusion Criteria

I've had a fever over 100.2°F and a cough or sore throat in the last 3 days without another known cause.
I agree to the study's terms and can stay in quarantine for about 5 days.
You have been diagnosed with the flu in the last 72 hours.
See 4 more

Exclusion Criteria

I am immunosuppressed or take medication that affects my immune system.
Known allergy or intolerance to treatments for influenza and other respiratory infections.
Any condition, to include medical and psychiatric conditions, that in the opinion of the Investigator, might interfere with the safety of the subject or the study objectives.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are exposed to controlled human influenza virus infection and interventions to reduce airborne transmission are implemented

2 weeks

Follow-up

Participants are monitored for serological, symptomatic, and viral confirmation of influenza infection

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • No Intervention
  • Personal Protective Equipment (PPE)
Trial Overview The EMIT-2 trial is testing how well Personal Protective Equipment (PPE) works under different air hygiene conditions to prevent airborne transmission of influenza. People will be randomly assigned to either use PPE or not under low and high air cleanliness settings.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Intervention RecipientsExperimental Treatment2 Interventions
Group II: DonorsExperimental Treatment2 Interventions
Group III: Control RecipientsActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Maryland, Baltimore

Lead Sponsor

Trials
729
Recruited
540,000+

University of Maryland, College Park

Collaborator

Trials
163
Recruited
46,800+

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator

Trials
3,361
Recruited
5,516,000+

Published Research Related to This Trial

The study found that the highest rates of non-percutaneous body fluid exposure (NP BFE) occurred in the emergency department (51.3%) and intensive care unit (30.8%), highlighting a significant risk for healthcare workers in these settings.
Despite nurses' awareness of the importance of using personal protective equipment (PPE) for preventing NP BFE, compliance was very low, with only 0% using face shields or masks, indicating a need for improved safety practices and training in high-risk areas.
Investigation of the selection and use of "other" personal protective equipment to prevent mucous membrane exposure in nurses: A cross-sectional study.Zimmerman, PA., Byrne, JH., Gillespie, BM., et al.[2023]
The implementation of a surgical safety checklist in an orthopedic department led to a significant reduction in postoperative fever, decreasing from 10.6% to 5.3% among patients, based on a study of 760 patients over a year.
The checklist also improved the administration of prophylactic antibiotics, with a notable increase in patients receiving appropriate preoperative treatment, which may have contributed to the reduction in fever rates.
Effect of Surgical Safety checklist implementation on the occurrence of postoperative complications in orthopedic patients.Boaz, M., Bermant, A., Ezri, T., et al.[2014]
A systematic review of 130 studies on muscle strengthening training (MST) in youth revealed that only 33.8% reported on adverse events (AEs), highlighting a significant gap in safety monitoring during these interventions.
Among the studies that did report AEs, 40.1% documented at least one adverse event, with over half of the reported events (59.1%) linked directly to the training or testing, indicating a need for better definitions and reporting practices in future research.
Reporting of Adverse Events in Muscle Strengthening Interventions in Youth: A Systematic Review.Mack, DE., Anzovino, D., Sanderson, M., et al.[2023]

Citations

Revisiting the personal protective equipment components ...Gloves are part of contact precautions that have been recommended for the prevention of the transmission of respiratory viruses such as ...
Rapid review and meta-analysis of the effectiveness of ...Overall, the review results show that wearing face masks can significantly protect HCWs from infection. We found no effects for wearing gloves and gowns.
3.infectiousdiseases-patientcare.wren-research-journals.cominfectiousdiseases-patientcare.wren-research-journals.com/1/article/view/18
A Systematic Review and Meta-Analysis of Health OutcomesConclusion: Our findings did not provide conclusive evidence for the effectiveness of influenza vaccination or face masks in reducing influenza ...
A Systematic Review and Meta-Analysis of Health OutcomesOur findings did not provide conclusive evidence for the effectiveness of influenza vaccination or face masks in reducing influenza infections.
Infection Prevention and Control Strategies for Seasonal ...This guidance emphasizes the importance of a comprehensive influenza prevention and control strategy that can be applied across the entire spectrum of ...
Personal Protective Equipment - OverviewPersonal protective equipment may include items such as gloves, safety glasses and shoes, earplugs or muffs, hard hats, respirators, or coveralls, vests and ...
Personal Protective Equipment - StatPearls - NCBI BookshelfCommonly worn PPE includes a gown, gloves, masks, respirators, and face shields or goggles. Understanding the limitations and proper wearing of PPE is ...
Use of personal protective equipment to protect against ...Goggles and face shields are used to prevent transfer of respiratory pathogens into the eyes from contaminated hands and other sources. Gowns, coveralls, ...
Protect yourself against flu: Learn more about preventive ...If used correctly, face masks can help reduce the risk of infection due to exposure to infectious droplets and aerosol, particularly if used ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security